Foreign Faculty

Global IPC unit, WHO, Gneva

Prof Benedetta Allegranzi

Global IPC unit, WHO, Gneva

Global IPC unit, WHO, Gneva

Prof Benedetta Allegranzi

Global IPC unit, WHO, Gneva

CDC, US

Dr Benjamin Park

CDC, US

CDC, US

Dr Benjamin Park

CDC, US

WHONET, Boston

Dr John Stelling

WHONET, Boston

WHONET, Boston

Dr John Stelling

WHONET, Boston

Hong Kong

Prof Malik Peiris

Hong Kong

Hong Kong

Prof Malik Peiris

Hong Kong

National University of Singapore

Prof Paul Anantharajah Tambyah

National University of Singapore

National University of Singapore

Prof Paul Anantharajah Tambyah

National University of Singapore

Curriculum Vitae (PI)

Name : Paul Anantharajah Tambyah
Title : Professor
NRIC/Passport no. : S168XXXXG
Office Mailing Address : 1E Kent Ridge Road, NUHS Tower Block, Level 10, Singapore 11922
Email : mdcpat@nus.edu.sg
Contact no. : 67795555

Employment History

2013 – present Professor, National University of Singapore
2007 – present Visiting Consultant, Singapore Armed Forces
2000 – present Visiting Consultant, Alexandra Hospital
2001 – 2010 Head, Division of Infectious, Department of Medicine, NUS

Academic Qualifications

MBBS, National University of Singapore (1988)
MD, National University of Singapore (2011)

Research Interests

Emerging infectious diseases and device associated infections

Appointments

Exco Member, ISID, Secretary General APSCMI

Selected Publications

Harris PN, Tambyah PA, Paterson DL. β-lactam and β-lactamase inhibitor combinations in the treatment of extended-spectrum β-lactamase producing Enterobacteriaceae: time for a reappraisal in the era of few antibiotic options? Lancet Infect Dis. 2015;15:475-85 (IF 19.9)
Bal C, Herbreteau CH, Buchy P, Rith S, Zaid M, Kristanto W, Han V, Reynaud C, Granjard P, Lépine B, Durand C, Tambyah PA. Safety, potential efficacy, and pharmacokinetics of specific polyclonal immunoglobulin F(ab’)(2) fragments against avian influenza A (H5N1) in healthy volunteers: a single-centre, randomised, double-blind, placebo-controlled, phase 1 study. Lancet Infect Dis. 2015 ;15:285-92 (IF 19.9)
Lye DC, Archuleta S, Syed-Omar SF, Low JG, Oh HM, Wei Y, Fisher D, Ponnampalavanar SSL, Wijaya L, Lee LK, Ooi EE, Kamarulzaman A, Lum LC, Tambyah PA, Leo YS. Prophylactic platelet transfusion plus supportive care versus supportive care alone in adults with dengue and thrombocytopenia: a multicentre, open-label, randomised, superiority trial. Lancet. 2017;389(10079):1611-1618 (IF 44.0)
Hsu LY, Apisarnthanarak A, Khan E, Suwantarat N, Ghafur A, Tambyah PA. Carbapenem-Resistant Acinetobacter baumannii and Enterobacteriaceae in South and Southeast Asia.Clin Microbiol Rev. 2017 ;30:1-22.
South East Asia Infectious Disease Clinical Research Network. Effect of double dose oseltamivir on clinical and virological outcomes in children and adults admitted to hospital with severe influenza: double blind randomised controlled trial. BMJ. 2013;346:f3039 (IF 19.9)
Lee VJ, Yap J, Cook AR, Chen MI, Tay JK, Tan BH, Loh JP, Chew SW, Koh WH, Lin R, Cui L, Lee CW, Sung WK, Wong CW, Hibberd ML, Kang WL, Seet B, Tambyah PA. Oseltamivir ring prophylaxis for containment of 2009 H1N1 influenza outbreaks. N Engl J Med. 2010;362:2166-74. (IF 72.4)
Tambyah PA, Koay ES, Poon ML, Lin RV, Ong BK; Transfusion-Transmitted Dengue Infection Study Group. Dengue hemorrhagic fever transmitted by blood transfusion. N Engl J Med. 2008;359:1526-7 (IF 72.4)
Ehrlich HJ, Müller M, Oh HML, Tambyah PA, Joukhadar C, Montomoli E, Fisher DA, Berezuk G, Fritsch S, Löw-Baselli A, Vartian N, Bobrovsky R, Pavlova BG, Pöllabauer EM, Kistner O, Barrett N. A Clinical Trial of a Whole-Virus H5N1 Vaccine Derived from Cell Culture. New Engl J Med 2008;358:2573-2584 (IF 72.4)

Scientific Awards

2014 YLLSOM Outstanding Researcher Award
2011 NUS Annual Teaching Excellence Award Honour Roll
2010 Rotating Professorship Award, Medical Alumni Association

Research Support (as Principal Investigator)

NMRC CTG – Ketotifen as a treatment for dengue fever – S$1.2 mil (USD$857,000)
NUHS H7N9 – Severe influenza ICU transmission study – S$100,000 (USD$71,400)
MOHCDPHRG12NOV25: Controlling antimicrobial use through reducing unnecessary treatment of catheter associated urinary tract infections – S$740,000 (USD $528,500)
SERC BEP 2010: POC_061 – Development of an Infection-resistant Urinary Catheter Coated by Short Antimicrobial Peptides – S$450,000 (USD$321,400)
NMRC/H1N1R/004/2009 –S$670,000 –micro RNAs in Influenza and other viral infections (USD$478,000)

Chair Infection Control Africa Network, South Africa

Prof Shaheen Mehtar

Chair Infection Control Africa Network, South Africa

Chair Infection Control Africa Network, South Africa

Prof Shaheen Mehtar

Chair Infection Control Africa Network, South Africa

Sri Manakula Vinayagar Medical College and Hospital, Puducherry, India

Dr J Shanmugam

Sri Manakula Vinayagar Medical College and Hospital, Puducherry, India

Sri Manakula Vinayagar Medical College and Hospital, Puducherry, India

Dr J Shanmugam

Sri Manakula Vinayagar Medical College and Hospital, Puducherry, India

Consultant Clinical Microbiologist, UK

Dr Anoma Geraldine Fernando

Consultant Clinical Microbiologist, UK

Consultant Clinical Microbiologist, UK

Dr Anoma Geraldine Fernando

Consultant Clinical Microbiologist, UK

Immunologist, UK

Prof Suranjith Seneviratne

Immunologist, UK

Immunologist, UK

Prof Suranjith Seneviratne

Immunologist, UK

Consultant Clinical Microbiologis

Dr Rohan Chinnnaiah

Consultant Clinical Microbiologis

Consultant Clinical Microbiologis

Dr Rohan Chinnnaiah

Consultant Clinical Microbiologis

Commonwealth Pharmacists Association (CPA)

Victoria Rutter

Commonwealth Pharmacists Association (CPA)

Commonwealth Pharmacists Association (CPA)

Victoria Rutter

Commonwealth Pharmacists Association (CPA)

Antibiotic pharmacist-UK

Yvonne Iroegbu

Antibiotic pharmacist-UK

Antibiotic pharmacist-UK

Yvonne Iroegbu

Antibiotic pharmacist-UK

MD - AFMC Pune – 1993, FRCPath - Royal College Of Pathologists UK

Dr. Ranganathan Iyer

MD - AFMC Pune – 1993, FRCPath - Royal College Of Pathologists UK

MD - AFMC Pune – 1993, FRCPath - Royal College Of Pathologists UK

Dr. Ranganathan Iyer

MD - AFMC Pune – 1993, FRCPath - Royal College Of Pathologists UK

Sector Manager - Legal and Clinical Services, National Association of Testing Authorities, Australia

Andrew Griffin

Sector Manager - Legal and Clinical Services, National Association of Testing Authorities, Australia

Sector Manager - Legal and Clinical Services, National Association of Testing Authorities, Australia

Andrew Griffin

Sector Manager - Legal and Clinical Services, National Association of Testing Authorities, Australia

ID Physician, Israel

Dr. Ami Neuberger

ID Physician, Israel

ID Physician, Israel

Dr. Ami Neuberger

ID Physician, Israel

Infectious disease clinician resident in Singapore

Dale Fisher

Infectious disease clinician resident in Singapore

Infectious disease clinician resident in Singapore

Dale Fisher

Infectious disease clinician resident in Singapore

Consultant Microbiologist, Australia

Dr. Shalini Perera

Consultant Microbiologist, Australia

Consultant Microbiologist, Australia

Dr. Shalini Perera

Consultant Microbiologist, Australia

Local Faculty

Consultant Virologist, MRI

Dr Jude Jayamaha

Consultant Virologist, MRI

Consultant Virologist, MRI

Dr Jude Jayamaha

Consultant Virologist, MRI

Consultant Immunologist, MRI

Dr. Rajiva de Silva

Consultant Immunologist, MRI

Consultant Immunologist, MRI

Dr. Rajiva de Silva

Consultant Immunologist, MRI

Deputy Director General Laboratory Services, Ministry of health

Dr. Hemantha Benaragama

Deputy Director General Laboratory Services, Ministry of health

Deputy Director General Laboratory Services, Ministry of health

Dr. Hemantha Benaragama

Deputy Director General Laboratory Services, Ministry of health

Hotel Taj Samudra

Colombo, Sri Lanka

August 08 - 11, 2018

08:30 AM – 05:00 PM

Free Lunch & Snacks

Don’t miss it